CME Group (NASDAQ:CME) Receives New Coverage from Analysts at Oppenheimer

Share on StockTwits

Oppenheimer started coverage on shares of CME Group (NASDAQ:CME) in a research report report published on Monday morning, BenzingaRatingsTable reports. The firm issued an outperform rating and a $234.00 price objective on the financial services provider’s stock.

Several other research firms also recently weighed in on CME. Barclays lifted their target price on shares of CME Group from $191.00 to $197.00 and gave the stock an overweight rating in a research report on Thursday, May 23rd. BidaskClub downgraded shares of CME Group from a buy rating to a hold rating in a research report on Thursday, September 12th. Zacks Investment Research downgraded shares of CME Group from a hold rating to a sell rating and set a $158.00 target price on the stock. in a research report on Monday, May 27th. UBS Group lifted their target price on shares of CME Group from $191.00 to $214.00 and gave the stock a neutral rating in a research report on Thursday, September 5th. Finally, Wells Fargo & Co lifted their target price on shares of CME Group from $176.00 to $200.00 and gave the stock a market perform rating in a research report on Wednesday, July 3rd. Three equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and seven have given a buy rating to the company. CME Group presently has an average rating of Hold and an average price target of $200.00.

NASDAQ CME opened at $211.95 on Monday. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.05 and a quick ratio of 1.05. The company’s 50 day simple moving average is $212.30 and its 200 day simple moving average is $192.06. CME Group has a 12 month low of $161.05 and a 12 month high of $224.91. The company has a market capitalization of $74.13 billion, a P/E ratio of 31.08, a PEG ratio of 4.42 and a beta of 0.19.

CME Group (NASDAQ:CME) last released its earnings results on Wednesday, July 31st. The financial services provider reported $1.76 earnings per share for the quarter, topping the consensus estimate of $1.75 by $0.01. The business had revenue of $1.27 billion for the quarter, compared to the consensus estimate of $1.27 billion. CME Group had a net margin of 39.36% and a return on equity of 9.14%. The firm’s quarterly revenue was up 20.1% compared to the same quarter last year. During the same period last year, the firm posted $1.74 earnings per share. On average, analysts anticipate that CME Group will post 6.73 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 25th. Investors of record on Tuesday, September 10th will be given a dividend of $0.75 per share. This represents a $3.00 dividend on an annualized basis and a yield of 1.42%. The ex-dividend date of this dividend is Monday, September 9th. CME Group’s payout ratio is presently 43.99%.

In related news, insider Sean Tully sold 7,200 shares of the business’s stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $223.13, for a total transaction of $1,606,536.00. Following the transaction, the insider now directly owns 19,923 shares of the company’s stock, valued at $4,445,418.99. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Terrence A. Duffy sold 35,000 shares of the business’s stock in a transaction that occurred on Thursday, August 1st. The shares were sold at an average price of $200.15, for a total transaction of $7,005,250.00. Following the transaction, the chief executive officer now directly owns 79,057 shares in the company, valued at $15,823,258.55. The disclosure for this sale can be found here. Insiders have sold 59,626 shares of company stock worth $12,255,934 over the last ninety days. 1.20% of the stock is currently owned by insiders.

A number of institutional investors and hedge funds have recently made changes to their positions in CME. Buckingham Asset Management LLC grew its position in CME Group by 1.4% in the second quarter. Buckingham Asset Management LLC now owns 3,607 shares of the financial services provider’s stock worth $700,000 after acquiring an additional 49 shares in the last quarter. IHT Wealth Management LLC grew its position in CME Group by 1.1% in the second quarter. IHT Wealth Management LLC now owns 4,404 shares of the financial services provider’s stock worth $855,000 after acquiring an additional 50 shares in the last quarter. Pitcairn Co. grew its position in CME Group by 2.3% in the second quarter. Pitcairn Co. now owns 2,239 shares of the financial services provider’s stock worth $435,000 after acquiring an additional 51 shares in the last quarter. Lourd Capital LLC grew its position in CME Group by 3.5% in the second quarter. Lourd Capital LLC now owns 1,620 shares of the financial services provider’s stock worth $314,000 after acquiring an additional 55 shares in the last quarter. Finally, Garner Asset Management Corp grew its position in CME Group by 1.1% in the second quarter. Garner Asset Management Corp now owns 5,200 shares of the financial services provider’s stock worth $1,009,000 after acquiring an additional 55 shares in the last quarter. 84.85% of the stock is currently owned by hedge funds and other institutional investors.

About CME Group

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

See Also: Balanced Fund

Analyst Recommendations for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.